← FDA Drug Approvals (Drugs@FDA)
ENZALUTAMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2021-05-14
Drug application
- FDA Application #
ANDA209614- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ENZALUTAMIDE
- Generic name
- Enzalutamide
- Active ingredients
- ENZALUTAMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ACTAVIS LABS FL INC
- First approval
- 2021-05-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown